tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Lifecore Biomedical Inc

LFCR
Add to Watchlist
4.720USD
-0.010-0.21%
Close 08-14 16:00（ET）Quotes delayed by 15 min
177.93MMarket Cap
LossP/E TTM

Lifecore Biomedical Inc

4.720
-0.010-0.21%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

LFCR Financials

See Lifecore Biomedical Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lifecore Biomedical Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
-0.19/-0.22
Revenue / Forecast
34.17M/32.02M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
75.52M
-41.12%
EPS(YoY)
-0.54
-236.63%
Analyst Rating
BUY
2026/08/15
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
25.11%-0.19
19.17%-0.43
76.16%-0.06
-191.56%-0.47
-154.26%-0.25
-48.71%-0.53
82.10%-0.23
142.56%0.51
208.02%0.47
---0.35
---1.30
---1.20
---0.43
---0.37
----
----
----
----
----
----
Revenue
4.92%34.17M
-6.12%23.19M
-3.81%36.44M
-1.54%35.15M
8.01%32.56M
0.75%24.70M
21.64%37.89M
34.55%35.70M
37.90%30.15M
3.36%24.52M
47.40%31.15M
-29.05%26.54M
-49.68%21.86M
-43.01%23.72M
-52.96%21.13M
-16.31%37.40M
-66.81%43.45M
-69.31%41.63M
-71.23%44.92M
-70.78%44.69M
Net Profit
18.11%-7.13M
1.82%-15.93M
71.10%-2.05M
-211.18%-17.38M
-161.21%-8.70M
-50.92%-16.23M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
1.93%-10.75M
29.34%-39.28M
-178.98%-36.51M
66.69%-12.81M
-15.71%-10.97M
-1839.95%-55.60M
-138.01%-13.09M
-189.01%-38.44M
13.85%-9.48M
81.08%-2.87M
52.27%-5.50M
Net Margin
10.71%-18.02%
1.68%-64.59%
83.17%-3.15%
-201.45%-42.01%
-142.72%-20.18%
-27.75%-65.70%
84.25%-18.70%
196.99%41.41%
212.25%47.24%
---51.42%
---118.79%
---42.70%
---42.08%
---28.27%
----
----
----
----
----
----
Gross Margin
3.83%35.34%
-11.77%19.24%
-15.85%38.37%
-15.93%28.01%
3.07%34.04%
96.01%21.81%
82.53%45.59%
3.41%33.31%
27.14%33.02%
--11.12%
--24.98%
--32.21%
--25.97%
--25.20%
----
----
----
----
----
----
Debt to assets ratio
44.04%67.57%
27.27%65.96%
11.11%53.06%
10.60%52.56%
5.08%46.91%
17.96%51.83%
15.34%47.76%
-2.38%47.52%
-15.22%44.64%
--43.94%
--41.41%
--48.68%
--52.66%
--52.98%
----
----
----
----
----
----
Income Statement
Revenue
4.92%34.17M
-6.12%23.19M
-3.81%36.44M
-1.54%35.15M
8.01%32.56M
0.75%24.70M
21.64%37.89M
34.55%35.70M
37.90%30.15M
3.36%24.52M
47.40%31.15M
-29.05%26.54M
-49.68%21.86M
-43.01%23.72M
-52.96%21.13M
-16.31%37.40M
-66.81%43.45M
-69.31%41.63M
-71.23%44.92M
-70.78%44.69M
Operating profit
345.27%3.81M
37.71%-4.67M
-51.56%2.90M
-187.09%-2.29M
-217.54%-1.56M
-32.81%-7.50M
140.77%5.99M
97.97%2.63M
166.28%1.32M
-83.73%-5.65M
-771.67%-14.68M
140.34%1.33M
-141.18%-2.00M
-238.55%-3.07M
-156.34%-1.68M
-173.86%-3.30M
147.42%4.85M
77.66%-908.00K
-33.49%2.99M
401.01%4.46M
Net Profit
18.11%-7.13M
1.82%-15.93M
71.10%-2.05M
-211.18%-17.38M
-161.21%-8.70M
-50.92%-16.23M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
1.93%-10.75M
29.34%-39.28M
-178.98%-36.51M
66.69%-12.81M
-15.71%-10.97M
-1839.95%-55.60M
-138.01%-13.09M
-189.01%-38.44M
13.85%-9.48M
81.08%-2.87M
52.27%-5.50M
Balance Sheet
Current assets
2.24%83.69M
4.66%77.64M
5.73%85.68M
10.58%84.21M
6.71%81.86M
-10.42%74.18M
-13.68%81.03M
-13.89%76.16M
-39.64%76.71M
-28.97%82.81M
-19.54%93.88M
-33.02%88.44M
-17.75%127.09M
-18.12%116.60M
-21.34%116.67M
-18.96%132.04M
0.22%154.52M
-3.36%142.41M
-5.59%148.32M
9.49%162.93M
Total current liabilities
-38.68%21.64M
-49.42%20.50M
-22.37%30.18M
-15.47%31.12M
-12.33%35.29M
14.43%40.52M
-1.06%38.87M
-2.29%36.81M
-79.43%40.25M
-80.21%35.41M
-77.75%39.29M
-58.17%37.67M
60.06%195.70M
72.66%178.96M
73.31%176.58M
-28.15%90.06M
-29.70%122.26M
-32.57%103.65M
-38.02%101.89M
-20.65%125.35M
Total assets
-10.14%229.50M
-8.64%225.50M
-5.76%239.34M
-3.47%237.69M
3.89%255.39M
0.49%246.82M
0.16%253.96M
4.27%246.24M
-11.92%245.82M
-8.72%245.62M
-7.70%253.54M
-27.47%236.15M
-33.89%279.07M
-39.61%269.10M
-45.38%274.70M
-36.14%325.58M
-15.43%422.12M
-11.96%445.62M
-7.09%502.92M
-7.32%509.82M
Total liabilities
9.09%213.41M
-1.25%204.72M
-4.07%191.91M
1.85%190.27M
-3.86%195.63M
-5.36%207.32M
-8.42%200.06M
14.30%186.81M
-0.70%203.47M
16.07%219.07M
16.90%218.46M
-9.96%163.44M
-22.95%204.91M
-25.03%188.73M
-37.74%186.88M
-40.53%181.51M
-8.37%265.92M
-11.67%251.75M
-3.26%300.14M
0.93%305.20M
Total equity
-73.07%16.09M
-47.40%20.78M
-12.00%47.43M
-20.20%47.43M
41.13%59.76M
48.76%39.50M
53.62%53.90M
-18.27%59.43M
-42.91%42.34M
-66.96%26.55M
-60.05%35.09M
-49.53%72.72M
-52.52%74.17M
-58.55%80.36M
-56.69%87.82M
-29.59%144.07M
-25.24%156.20M
-12.34%193.87M
-12.23%202.78M
-17.38%204.62M
Cash Flow Statement
Net operating income
64.17%-2.19M
830.95%4.70M
-38.11%5.35M
178.23%1.20M
-574.38%-6.11M
92.28%-643.00K
3276.47%8.64M
86.92%-1.53M
154.74%1.29M
-656.49%-8.33M
50.36%-272.00K
33.90%-11.72M
54.20%-2.35M
-232.49%-1.10M
-109.33%-548.00K
-125.80%-17.74M
-457.98%-5.14M
-95.12%831.00K
146.22%5.87M
-174.23%-7.86M
Net investment
79.23%-513.00K
67.04%-1.12M
20.48%-2.10M
124.70%1.54M
42.03%-2.47M
32.88%-3.39M
67.68%-2.64M
-215.10%-6.25M
-10.73%-4.26M
-2136.28%-5.05M
56.62%-8.16M
-91.72%5.43M
24.50%-3.85M
-100.59%-226.00K
-36.15%-18.80M
1749.77%65.59M
-197.16%-5.10M
16395.26%38.27M
-202.50%-13.81M
-7.87%-3.98M
Net financing
-106.81%-852.00K
-123.42%-256.00K
34.53%-402.00K
-188.80%-6.78M
611.23%12.52M
-62.75%1.09M
-102.50%-614.00K
216.36%7.64M
-127.79%-2.45M
-24.88%2.93M
28.36%24.57M
105.13%2.41M
-10.82%8.81M
110.03%3.91M
173.93%19.14M
-506.36%-47.09M
298.67%9.88M
-128.78%-38.95M
-53.48%6.99M
290.70%11.59M

FAQs

What is the total revenue of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its total revenue reached 75.52M, with a year-on-year change of 128.26M.

What are the current assets of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its current assets were 82.29M, with a year-on-year change of 1.55.

What are the total assets of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its total assets of Lifecore Biomedical Inc were 232.18M, with a year-on-year change of -8.58.

What are the total liabilities of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its total liabilities of Lifecore Biomedical Inc were 198.12M, with a year-on-year change of -0.97.

What is the total equity of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its total equity of Lifecore Biomedical Inc was 34.06M, with a year-on-year change of -36.81.

What is the net operating income of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its net operating income of Lifecore Biomedical Inc was -733.00K, with a year-on-year change of -117.08.

What is the net investment of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its net investment of Lifecore Biomedical Inc was 6.30M, with a year-on-year change of 135.18.

What is the net financing of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its net financing of Lifecore Biomedical Inc was -4.43M, with a year-on-year change of -159.00.

What is the Earnings Per Share (EPS) of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.54, with a year-on-year change of -236.63.

What is the net income of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its net income was -20.13M, with a year-on-year change of -267.54.

What is the net margin of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its net profit margin was -23.78, with a year-on-year change of -426.91.

What is the gross margin of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its gross margin was 31.37, with a year-on-year change of -3.87.

What is the debt-to-asset ratio of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its debt-to-asset ratio was 61.26, with a year-on-year change of 24.80.

What is the Return on Equity (ROE) of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its Return on Equity (ROE) was -701.27, with a year-on-year change of -366.24.

What is the Return on Assets (ROA) of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its Return on Assets (ROA) was -15.70, with a year-on-year change of -526.88.

What is the operating profit of Lifecore Biomedical Inc?

According to Lifecore Biomedical Inc's FY2025 earnings report, its operating profit was -733.00K, with a year-on-year change of -117.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy